Lead Optimization of Ethyl 6-Aminonicotinate Acyl Sulfonamides as Antagonists of the P2Y12 Receptor. Separation of the Antithrombotic Effect and Bleeding for Candidate Drug AZD1283
Citations Over TimeTop 10% of 2013 papers
Abstract
Synthesis and structure-activity relationships of ethyl 6-aminonicotinate acyl sulfonamides, which are potent antagonists of the P2Y12 receptor, are presented. Shifting from 5-chlorothienyl to benzyl sulfonamides significantly increased the potency in the residual platelet count assay. Evaluation of PK parameters in vivo in dog for six compounds showed a 10-fold higher clearance for the azetidines than for the matched-pair piperidines. In a modified Folts model in dog, both piperidine 3 and azetidine 13 dose-dependently induced increases in blood flow and inhibition of ADP-induced platelet aggregation with antithrombotic ED50 values of 3.0 and 10 μg/kg/min, respectively. The doses that induced a larger than 3-fold increase in bleeding time were 33 and 100 μg/kg/min for 3 and 13, respectively. Thus, the therapeutic index (TI) was ≥ 10 for both compounds. On the basis of these data, compound 3 was progressed into human clinical trials as candidate drug AZD1283.
Related Papers
- → Biosyntheses of azetidine-containing natural products(2023)19 cited
- → Effect of the Azetidine and Azocine Rings of Okaramine B on Insecticidal Activity(2000)45 cited
- → The first application of the Baylis–Hillman reaction in azetidine chemistry: a convenient synthesis of azetidine-3-carbonitriles/carboxylates(2008)43 cited
- → Studies on Azetidine Derivatives. I. Synthesis of 3-Substituted Azetidine Derivatives(1974)38 cited
- → ChemInform Abstract: STUDIES ON AZETIDINE DERIVATIVES PART 1, SYNTHESIS OF 3-SUBSTITUTED AZETIDINE DERIVATIVES(1974)